NDC 69097-313

GEMCITABINE HYDROCHLORIDE

Gemcitabine Hydrochloride

GEMCITABINE HYDROCHLORIDE is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Gemcitabine Hydrochloride.

Product ID69097-313_3a57a223-6d5c-4ca9-b504-01a25e7cee18
NDC69097-313
Product TypeHuman Prescription Drug
Proprietary NameGEMCITABINE HYDROCHLORIDE
Generic NameGemcitabine Hydrochloride
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2011-07-25
Marketing CategoryANDA / ANDA
Application NumberANDA078759
Labeler NameCipla USA Inc.
Substance NameGEMCITABINE HYDROCHLORIDE
Active Ingredient Strength200 mg/5mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69097-313-37

1 VIAL, SINGLE-USE in 1 CARTON (69097-313-37) > 5 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2011-07-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69097-313-37 [69097031337]

GEMCITABINE HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA078759
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-25

Drug Details

Active Ingredients

IngredientStrength
GEMCITABINE HYDROCHLORIDE200 mg/5mL

OpenFDA Data

SPL SET ID:b4e58ed9-edb8-4337-ad0d-29e075e66f1d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1719000
  • 1719003
  • UPC Code
  • 0369097314422
  • Pharmacological Class

    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]

    NDC Crossover Matching brand name "GEMCITABINE HYDROCHLORIDE" or generic name "Gemcitabine Hydrochloride"

    NDCBrand NameGeneric Name
    16729-092GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE
    16729-117GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE
    16729-118GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE
    23155-213Gemcitabine hydrochlorideGemcitabine hydrochloride
    23155-214Gemcitabine hydrochlorideGemcitabine hydrochloride
    23155-483Gemcitabine hydrochlorideGemcitabine hydrochloride
    23155-484Gemcitabine hydrochlorideGemcitabine hydrochloride
    23155-528Gemcitabine hydrochlorideGemcitabine hydrochloride
    23155-529Gemcitabine hydrochlorideGemcitabine hydrochloride
    45963-612gemcitabine hydrochloridegemcitabine hydrochloride
    45963-619gemcitabine hydrochloridegemcitabine hydrochloride
    45963-620gemcitabine hydrochloridegemcitabine hydrochloride
    68001-282Gemcitabine HydrochlorideGemcitabine Hydrochloride
    68083-149gemcitabine hydrochloridegemcitabine hydrochloride
    68083-148gemcitabine hydrochloridegemcitabine hydrochloride
    69097-314GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE
    69097-313GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE
    67457-462GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE
    67457-463GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE
    67457-464GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE
    16714-909GEMCITABINEGEMCITABINE HYDROCHLORIDE
    16714-930GEMCITABINEGEMCITABINE HYDROCHLORIDE
    25021-234gemcitabinegemcitabine hydrochloride
    25021-235gemcitabinegemcitabine hydrochloride
    0002-7501GemzarGemcitabine hydrochloride
    0002-7502GemzarGemcitabine hydrochloride

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.